Phase III Study of Cisplatin With or Without Paclitaxel in Stage IVB, Recurrent, or Persistent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study
David H. Moore(Gynecologic Oncology Group), Thomas F. Rocereto(Gynecologic Oncology Group), David S. Miller(Southwestern Medical Center), David Cella(Northwestern University), John F. Boggess(University of Kentucky), Stephanie King(Gynecologic Oncology Group), Howard T. Thaler(Memorial Sloan Kettering Cancer Center), Richard P. McQuellon(Wake Forest University), John A. Blessing(Gynecologic Oncology Group), J Bénda, George J. Olt(Gynecologic Oncology Group)
Cited by 644
Related Papers
The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008
|Journal of Clinical Epidemiology|2010|5.1k
Impact of Cancer-Related Fatigue on the Lives of Patients: New Findings From the Fatigue Coalition
|The Oncologist|2000|1.3k
Cancer-Related Fatigue, Version 2.2015
|Journal of the National Comprehensive Cancer Network|2015|951
A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study
|The Lancet Oncology|2017|929
Effects of Testosterone Treatment in Older Men
|New England Journal of Medicine|2016|864